Clinical Usefulness of Sitafloxacin-Based Triple Therapy as a Third Line Regimen for Helicobacter pylori Eradication in Japan

被引：0
|
作者：
Hirata, Yoshihiro
Ohmae, Tomoya
Yanai, Ayako
Sakitani, Kosuke
Hayakawa, Yoku
Yoshida, Shuntaro
Sugimoto, Takafumi
Maeda, Shin
Koike, Kazuhiko
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S879 / S879
页数：1
相关论文
共 50 条
  • [1] Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan
    Hirata, Yoshihiro
    Ohmae, Tomoya
    Yanai, Ayako
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yoshida, Shuntaro
    Sugimoto, Takafumi
    Mitsuno, Yuzo
    Akanuma, Masao
    Yamaji, Yutaka
    Ogura, Keiji
    Maeda, Shin
    Koike, Kazuhiko
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (04) : 352 - 355
  • [2] Triple therapy of vonoprazan, amoxicillin and sitafloxacin is useful third-line regimen for Helicobacter pylori eradication in Japan
    Shimoyama, T.
    Chinda, D.
    Fukuda, S.
    [J]. HELICOBACTER, 2017, 22
  • [3] Efficacy of Triple Therapy of Vonoprazan, Amoxicillin, and Sitafloxacin as the Third-Line Regimen for Helicobacter pylori Eradication in Japan
    Shimoyama, Tadashi
    Higuchi, Naoki
    Oyama, Takao
    Higuchi, Hiroyuki
    Chinda, Daisuke
    Fukuda, Shinsaku
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S498 - S498
  • [4] Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
    Hirata, Yoshihiro
    Serizawa, Takako
    Shichijo, Satoki
    Suzuki, Nobumi
    Sakitani, Kosuke
    Hayakawa, Yoku
    Yamada, Atsuo
    Koike, Kazuhiko
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 66 - 69
  • [5] Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan
    Furuta, Takahisa
    Sugimoto, Mitsushige
    Kodaira, Chise
    Nishino, Masafumi
    Yamade, Mihoko
    Uotani, Takahiro
    Sahara, Shu
    Ichikawa, Hitomi
    Yamada, Takanori
    Osawa, Satoshi
    Sugimoto, Ken
    Watanabe, Hiroshi
    Umemura, Kazuo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 487 - 493
  • [6] Sitafloxacin-Based Third-Line Eradication of H. pylori
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Nishizawa, Toshihiro
    Saito, Yoshimasa
    Hirata, Kenro
    Tsugawa, Hitoshi
    Muraoka, Hiroe
    Hibi, Toshifumi
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S340 - S340
  • [7] High Helicobacter pylori cure rate with sitafloxacin-based triple therapy
    Sugimoto, M.
    Sahara, S.
    Ichikawa, H.
    Kagami, T.
    Uotani, T.
    Furuta, T.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 477 - 483
  • [8] DIVIDING HIGH-DOSE PPI/SITAFLOXACIN-BASED TRIPLE HELICOBACTOR PYLORI ERADICATION THERAPY IS USEFULNESS AS THIRD-LINE THERAPY IN JAPANESE: PRELIMINARY STUDY
    Uotani, T.
    Sugimoto, M.
    Ichikawa, H.
    Sahara, S.
    Furuta, T.
    [J]. HELICOBACTER, 2013, 18 : 134 - 134
  • [9] Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication
    Nishizawa, Toshihiro
    Suzuki, Hidekazu
    Nakagawa, Izumi
    Iwasaki, Eisuke
    Masaoka, Tatsuhiro
    Hibi, Toshifumi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : S167 - S170
  • [10] Levofloxacin based triple therapy for third line Helicobacter pylori eradication
    Lee, M.
    Kim, G.
    Lee, B.
    Song, G.
    Park, S.
    Park, S.
    Park, J.
    Kim, S.
    [J]. HELICOBACTER, 2018, 23
12345